Table 1 Therapeutic value of new drugs assessed with the Motola’s rating system
From: Assessment of the therapeutic value of new medicines marketed in Australia
Disease seriousness | ||||
|---|---|---|---|---|
Therapeutic innovation | Drug for serious diseases | Drug for risk factors for serious diseases | Drug for non serious diseases | Total |
Important | 7 | - | - | 7 (11.9%) |
Moderate | 17 | - | - | 17 (28.8%) |
Modest | 3 | 1 | - | 4 (6.8%) |
Pharmacological | 5 | 1 | - | 6 (10.2%) |
Technological | 22 | 1 | 2 | 25 (42.4%) |
TOTAL | 54 (91.5%) | 3 (5.1%) | 2 (3.4%) | 59 (100.0%) |